Revenio Group Oyj
ISIN: FI0009010912 | Ticker: REG1V | LEI: 743700I27E0FWSXLKK04
Country: Finland
Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).
The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Icare World Australia Pty Ltd, CT Operations International UK Ltd, Done Medical Oy and Oscare Medical Oy.
Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Worldwide
HeadquartersÄyritie 22, 1510 Vantaa – Finland
| Line item in (eur) | 02.01.2019 | 01.01.2020 | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 02.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|---|---|
| Assets | N/A | 109,791,000.00 | N/A | 114,419,000.00 | N/A | 124,583,000.00 | N/A | 136,091,000.00 |
| Noncurrent Assets | N/A | 72,496,000.00 | N/A | 70,378,000.00 | N/A | 83,731,000.00 | N/A | 83,592,000.00 |
| Property Plant And Equipment | N/A | 1,809,000.00 | N/A | 2,018,000.00 | N/A | 2,554,000.00 | N/A | 2,848,000.00 |
| Goodwill | N/A | 50,409,000.00 | N/A | 50,409,000.00 | N/A | 59,815,000.00 | N/A | 59,768,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 19,438,000.00 | N/A | 16,861,000.00 | N/A | 17,969,000.00 | N/A | 17,083,000.00 |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | 1,308,000.00 | N/A | 1,589,000.00 |
| Other Noncurrent Financial Assets | N/A | N/A | N/A | N/A | N/A | 200,000.00 | N/A | 417,000.00 |
| Current Assets | N/A | 37,295,000.00 | N/A | 44,041,000.00 | N/A | 40,852,000.00 | N/A | 52,500,000.00 |
| Current Tax Assets Current | N/A | N/A | N/A | 714,000.00 | N/A | 139,000.00 | N/A | 806,000.00 |
| Cash and cash equivalents | 10,378,000.00 | 26,675,000.00 | 26,675,000.00 | 28,878,000.00 | 28,878,000.00 | 25,216,000.00 | 25,216,000.00 | 32,062,000.00 |
| Equity And Liabilities | N/A | 109,791,000.00 | N/A | 114,419,000.00 | N/A | 124,583,000.00 | N/A | 136,091,000.00 |
| Equity | 18,042,000.00 | 64,363,000.00 | 64,363,000.00 | 69,710,000.00 | N/A | 78,429,000.00 | N/A | 90,916,000.00 |
| Issued Capital | N/A | 5,315,000.00 | N/A | 5,315,000.00 | N/A | 5,315,000.00 | N/A | 5,315,000.00 |
| Retained Earnings | N/A | 7,999,000.00 | N/A | 13,971,000.00 | N/A | 22,125,000.00 | N/A | 34,290,000.00 |
| Treasury Shares | N/A | 740,000.00 | N/A | 2,333,000.00 | N/A | 2,149,000.00 | N/A | 1,907,000.00 |
| Other Reserves | N/A | 280,000.00 | N/A | 280,000.00 | N/A | 280,000.00 | N/A | 280,000.00 |
| Reserve Of Sharebased Payments | N/A | 300,000.00 | N/A | 300,000.00 | N/A | 300,000.00 | N/A | N/A |
| Liabilities | N/A | 45,428,000.00 | N/A | 44,709,000.00 | N/A | 46,154,000.00 | N/A | 45,175,000.00 |
| Noncurrent Liabilities | N/A | 29,888,000.00 | N/A | 26,591,000.00 | N/A | 5,588,000.00 | N/A | 19,511,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 428,000.00 | N/A | 701,000.00 | N/A | 777,000.00 | N/A | 740,000.00 |
| Deferred Tax Liabilities | N/A | 4,120,000.00 | N/A | 3,856,000.00 | N/A | 3,909,000.00 | N/A | 3,656,000.00 |
| Other Noncurrent Liabilities | N/A | 1,155,000.00 | N/A | 0.00 | N/A | N/A | N/A | N/A |
| Longterm Borrowings | N/A | 23,817,000.00 | N/A | 21,659,000.00 | N/A | 0.00 | N/A | 14,250,000.00 |
| Current Liabilities | N/A | 15,540,000.00 | N/A | 18,118,000.00 | N/A | 40,566,000.00 | N/A | 25,664,000.00 |
| Current Provisions | N/A | 397,000.00 | N/A | 330,000.00 | N/A | 476,000.00 | N/A | 485,000.00 |
| Current Tax Liabilities Current | N/A | 0.00 | N/A | -714,000.00 | N/A | N/A | N/A | N/A |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 4,259,000.00 | N/A | 4,604,000.00 | N/A | 22,709,000.00 | N/A | 4,200,000.00 |
| Line item in (eur) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue From Contracts With Customers | 49,474,000.00 | 61,067,000.00 | 78,778,000.00 | 96,976,000.00 |
| Other Income | 1,311,000.00 | 1,316,000.00 | 850,000.00 | 307,000.00 |
| Changes In Inventories Of Finished Goods And Work In Progress | 5,396,000.00 | -759,000.00 | -1,537,000.00 | -181,000.00 |
| Raw Materials And Consumables Used | 5,899,000.00 | 14,095,000.00 | 18,879,000.00 | 21,581,000.00 |
| Services Expense | 3,642,000.00 | 4,392,000.00 | 5,681,000.00 | 5,806,000.00 |
| Employee Benefits Expense | 9,772,000.00 | 12,718,000.00 | 16,425,000.00 | 19,351,000.00 |
| Wages And Salaries | 8,325,000.00 | 11,023,000.00 | 14,369,000.00 | 16,654,000.00 |
| Social Security Contributions | 291,000.00 | 250,000.00 | 1,020,000.00 | 1,251,000.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 2,023,000.00 | 4,563,000.00 | 3,620,000.00 | 3,434,000.00 |
| Depreciation And Amortisation Expense | 2,023,000.00 | 2,606,000.00 | 2,992,000.00 | 3,434,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 1,956,000.00 | 628,000.00 | 0.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 1,956,000.00 | 628,000.00 | 0.00 |
| Other Expense By Nature | 11,460,000.00 | 10,244,000.00 | 14,457,000.00 | 17,609,000.00 |
| Profit Loss From Operating Activities | 12,593,000.00 | 17,130,000.00 | 22,103,000.00 | 29,683,000.00 |
| Finance Income | 5,000.00 | 1,000.00 | 248,000.00 | 53,000.00 |
| Finance Costs | 325,000.00 | 412,000.00 | 252,000.00 | 680,000.00 |
| Profit Loss Before Tax | 12,273,000.00 | 16,719,000.00 | 22,099,000.00 | 29,056,000.00 |
| Income Tax Expense Continuing Operations | 2,930,000.00 | 3,357,000.00 | 4,778,000.00 | 7,303,000.00 |
| Profit (loss) | 9,343,000.00 | 13,362,000.00 | 17,321,000.00 | 21,753,000.00 |
| Line item in (eur) | 01.01.2020 | 02.01.2019 | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 | 02.01.2022 |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) | 9,343,000.00 | N/A | 13,362,000.00 | N/A | 17,321,000.00 | N/A | 21,753,000.00 | N/A |
| Adjustments For Income Tax Expense | 3,112,000.00 | N/A | 3,357,000.00 | N/A | 4,778,000.00 | N/A | 7,303,000.00 | N/A |
| Adjustments For Decrease Increase In Inventories | 729,000.00 | N/A | -1,423,000.00 | N/A | -1,539,000.00 | N/A | -327,000.00 | N/A |
| Adjustments For Sharebased Payments | N/A | N/A | 0.00 | N/A | -1,077,000.00 | N/A | -950,000.00 | N/A |
| Other Adjustments For Noncash Items | 1,775,000.00 | N/A | 539,000.00 | N/A | 569,000.00 | N/A | 529,000.00 | N/A |
| Interest Paid Classified As Operating Activities | -291,000.00 | N/A | 265,000.00 | N/A | 247,000.00 | N/A | 344,000.00 | N/A |
| Interest Received Classified As Operating Activities | 5,000.00 | N/A | 1,000.00 | N/A | 1,000.00 | N/A | 53,000.00 | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | -3,663,000.00 | N/A | 3,436,000.00 | N/A | 4,513,000.00 | N/A | 6,014,000.00 | N/A |
| Cash Flows From Used In Operating Activities | 12,489,000.00 | N/A | 15,230,000.00 | N/A | 21,509,000.00 | N/A | 23,241,000.00 | N/A |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 58,227,000.00 | N/A | 0.00 | N/A | 11,322,000.00 | N/A | 0.00 | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 824,000.00 | N/A | 840,000.00 | N/A | 1,235,000.00 | N/A | 1,113,000.00 | N/A |
| Purchase Of Intangible Assets Classified As Investing Activities | 661,000.00 | N/A | 702,000.00 | N/A | 780,000.00 | N/A | 883,000.00 | N/A |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | 0.00 | N/A | 50,000.00 | N/A | 200,000.00 | N/A | 160,000.00 | N/A |
| Cash Flows From Used In Investing Activities | -59,713,000.00 | N/A | -1,591,000.00 | N/A | -13,538,000.00 | N/A | -2,155,000.00 | N/A |
| Proceeds From Issuing Shares | 42,300,000.00 | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A |
| Payments To Acquire Or Redeem Entitys Shares | 0.00 | N/A | 1,613,000.00 | N/A | 0.00 | N/A | N/A | N/A |
| Repayments Of Borrowings Classified As Financing Activities | 2,248,000.00 | N/A | 2,159,000.00 | N/A | 3,209,000.00 | N/A | 4,259,000.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | 580,000.00 | N/A | 659,000.00 | N/A | 708,000.00 | N/A | 846,000.00 | N/A |
| Dividends Paid Classified As Financing Activities | 6,709,000.00 | N/A | 7,948,000.00 | N/A | 8,498,000.00 | N/A | 9,036,000.00 | N/A |
| Cash Flows From Used In Financing Activities | 63,549,000.00 | N/A | -11,075,000.00 | N/A | -12,140,000.00 | N/A | -14,141,000.00 | N/A |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 16,326,000.00 | N/A | 2,564,000.00 | N/A | -4,169,000.00 | N/A | 6,944,000.00 | N/A |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 54.00 | N/A | -360,000.00 | N/A | 507,000.00 | N/A | -99,000.00 | N/A |
| Cash and cash equivalents | 26,675,000.00 | 10,378,000.00 | 28,878,000.00 | 26,675,000.00 | 25,216,000.00 | 28,878,000.00 | 32,062,000.00 | 25,216,000.00 |
Please note that some sums might not add up.
FI0009010912
LEI743700I27E0FWSXLKK04
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.